Skip to main content

RYAN SPECIALTY HOLDINGS, INC.

corporate_fare Company Profile

RYAN SPECIALTY HOLDINGS, INC.

RYAN·NYSE·Finance·CIK 0001849253

Ryan Specialty is an international specialty insurance intermediary founded in 2010 by Patrick G. Ryan. The company offers specialty insurance products, solutions, and services to insurance brokers, agents, and carriers. Ryan Specialty provides distribution, underwriting, product development, administration, and risk management services through its wholesale brokerage platform. It also offers delegated underwriting authority services on behalf of insurance carriers through its managing underwriter, binding authority, and national program operations. The company's expertise covers a wide range of insurance types, including property, casualty, professional lines, transportation, personal lines, workers' compensation, and employee benefits insurance. For retail insurance brokers, Ryan Specialty helps place complex or hard-to-place risks. For insurance carriers, it collaborates with retail and wholesale insurance brokers to source, onboard, underwrite, and service these types of risks. A significant majority of the premiums placed by Ryan Specialty are bound in the Excess & Surplus (E&S) market, which includes Lloyd's of London. The E&S market offers greater flexibility in terms, conditions, and rates compared to the Admitted or "standard" insurance market. Retail insurance brokers, including global, national, regional, and local firms, rely on Ryan Specialty for expertise in specialty insurance lines and access to coverage options for insureds.

RYAN SPECIALTY HOLDINGS, INC. (NYSE:RYAN) is a publicly traded company in the Finance sector. Wiseek has independently scored 9 items for RYAN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-31, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for RYAN spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Ryan Specialty Q2 Revenue Hits $916.6M, Adjusted EPS $0.74; $300M Buyback Continues
  • Ryan Specialty Q2 Revenue Beats by 5%, EPS Crushes Estimates by 23%
  • Ryan Specialty Q2 Earnings Beat, Raises Guidance Margin Outlook
  • Ryan Specialty Increases Share Buyback Program by $300M to $600M Total
  • Ryan Specialty boosts share buyback program by $300M, doubling total authorization to $600M

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.05B
Net Income
$63.4M
Op. Cash Flow
$643.67M
Free Cash Flow
$640.65M
Operating Income
$493.64M
Cash & Equivalents
$158.32M
Total Debt
$3.35B
Debt / Equity
5.17×
Net Margin
2.1%
Source: 10-K · filed 2026-02-13 · accession 0001849253-26-000006

Short Interest & Short Volume

6.51 days to cover

FINRA reported short interest of 11,977,334 shares in RYAN as of the September 15, 2026 settlement, a 10.7% decrease from the prior period — about 6.5 days to cover at its recent average daily volume. On October 2, 2026, 75.8% of RYAN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)11,977,334 shares as of September 15, 2026
Change vs prior period▼ 10.7%
Days to cover6.51 at avg daily volume of 1,839,758
Daily short volume (FINRA facilities)75.8% of 605,614 shares on October 2, 2026
5-day average short volume73.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$37.67
52-week range · as of 2026-07-31 $29.28 – $61.85
Market cap
$9.64B
Volume
2.1M (1.1× avg)
3-mo avg 1.9M
Live data · 2026-10-03 19:08 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RYAN - Latest Insights

RYAN
Jul 31, 2026, 7:32 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $49.25
Real-time Price: $37.67 info
Change: -$11.58 (-24%) info
Market Cap: $9.637B info
RYAN
Jul 30, 2026, 4:31 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $49.50
Real-time Price: $37.67 info
Change: -$11.83 (-24%) info
Market Cap: $9.637B info
RYAN
Jul 30, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.50
Real-time Price: $37.67 info
Change: -$11.83 (-24%) info
Market Cap: $9.637B info
RYAN
May 26, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $33.54
Real-time Price: $37.67 info
Change: +$4.13 (+12%) info
Market Cap: $9.637B info
RYAN
May 26, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $32.68
Real-time Price: $37.67 info
Change: +$4.99 (+15%) info
Market Cap: $9.637B info
RYAN
Apr 30, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $34.50
Real-time Price: $37.67 info
Change: +$3.17 (+9%) info
Market Cap: $9.637B info
RYAN
Mar 17, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $35.98
Real-time Price: $37.67 info
Change: +$1.69 (+5%) info
Market Cap: $9.637B info
RYAN
Feb 13, 2026, 7:20 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $40.00
Real-time Price: $37.67 info
Change: -$2.33 (-6%) info
Market Cap: $9.637B info
RYAN
Feb 12, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.81
Real-time Price: $37.67 info
Change: -$5.14 (-12%) info
Market Cap: $9.637B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets